The European Medicines Agency announced a study last fall that found the UK’s most widely prescribed antidepressant, Citalopram, causes 3x more cardiac abnormalities, including fatal ones, than other antidepressants. The UK’s Medicines and Healthcare products Regulatory Agency is receiving criticism for not making the recommendation public. The recommendation is for a lower dosage, though there is no research on the safety of the lower dose.
Antidepressant citalopram heart safety warning
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.